C-myc inhibitors have been widely used in vivo and in vitro to induce cycle arrest and apoptosis in cancer cells and enhance chemosensitivity.42,43 Further studies of these inhibitors as antitumor agents in colon cancer, especially in RCC, might be valuable. Here, MYC is linked to renal cell carcinoma.